Close Menu

NEW YORK (GenomeWeb) – Cedars-Sinai plans this fall to open a research and clinical laboratory focused on validating and implementing disease biomarkers.

Called the Cedars-Sinai Precision Biomarker Lab, the facility will be mass spectrometry-focused and will comprise both a research service contract lab for building and validating protein biomarker tests as well as a CAP-accredited, CLIA-certified lab for offering protein biomarker tests clinically, said Jennifer Van Eyk, codirector of the hospital's Precision Medicine Initiative.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.